Saba Capital Management L.P. boosted its position in Abrdn Life Sciences Investors (NYSE:HQL – Free Report) by 98.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 271,607 shares of the company’s stock after purchasing an additional 134,644 shares during the […]